1-20 of 35
Authors: Daniel P. Cahill
Save search
Sort by
Journal Article

A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology

PDF
Cecile Riviere-Cazaux and others
Neuro-Oncology, noae276, https://doi.org/10.1093/neuonc/noae276
Published: 30 December 2024
Journal Article

EPCO-20. MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA

PDF
Avishay Spitzer and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii5, https://doi.org/10.1093/neuonc/noae165.0019
Published: 11 November 2024
Journal Article

TMIC-26. IMMUNE CELL DYNAMICS WITHIN GLIOMAS: THE INFLUENCE OF GRADE AND IDH STATUS

PDF
Eric P Grewal and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii303, https://doi.org/10.1093/neuonc/noae165.1204
Published: 11 November 2024
Journal Article

NCOG-30. FACTORS ASSOCIATED WITH COGNITIVE IMPAIRMENT IN LONG-TERM IDH-MUTANT GLIOMA SURVIVORS

PDF
Tyler Lanman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii231, https://doi.org/10.1093/neuonc/noae165.0912
Published: 11 November 2024
Journal Article

DDDR-24. REAL WORLD EXPERIENCE USING THE IDH INHIBITOR IVOSIDENIB IN IDH MUTANT GLIOMA: TOLERABILITY AND OUTCOMES

PDF
Tyler Lanman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii130–viii131, https://doi.org/10.1093/neuonc/noae165.0509
Published: 11 November 2024
Journal Article

SURG-21. DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANORESECT GROUP

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii278, https://doi.org/10.1093/neuonc/noae165.1101
Published: 11 November 2024
Journal Article

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: a report of the RANO resect group

PDF
Philipp Karschnia and others
Neuro-Oncology, noae231, https://doi.org/10.1093/neuonc/noae231
Published: 04 November 2024
Journal Article

Thrombosis, brain metastasis formation, and the perivascular metastatic niche—Novel insights from the tumor microvascular circulation Get access

PDF
Christopher Alvarez-Breckenridge and others
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2100–2101, https://doi.org/10.1093/neuonc/noae168
Published: 29 August 2024
Journal Article

Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma

PDF
Elie Massaad and others
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1660–1669, https://doi.org/10.1093/neuonc/noae073
Published: 06 April 2024
Journal Article

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

PDF
Albert E Kim and others
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 965–974, https://doi.org/10.1093/neuonc/noad236
Published: 09 December 2023
Journal Article

Considering the extent of resection in diffuse glioma

PDF
Daniel P Cahill and Gavin P Dunn
Neuro-Oncology, Volume 25, Issue 12, December 2023, Pages 2134–2135, https://doi.org/10.1093/neuonc/noad165
Published: 07 September 2023
Journal Article

Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 166–177, https://doi.org/10.1093/neuonc/noad160
Published: 04 September 2023
Journal Article

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 25, Issue 12, December 2023, Pages 2239–2249, https://doi.org/10.1093/neuonc/noad118
Published: 04 July 2023
Journal Article
EDITOR'S CHOICE

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

PDF
Julie J Miller and others
Neuro-Oncology, Volume 25, Issue 1, January 2023, Pages 4–25, https://doi.org/10.1093/neuonc/noac207
Published: 12 October 2022
Journal Article

Enhancing demethylation-induced differentiation in IDH-mutant glioma

PDF
Julie J Miller and others
Neuro-Oncology, Volume 24, Issue 5, May 2022, Pages 724–725, https://doi.org/10.1093/neuonc/noac056
Published: 03 March 2022
Journal Article

Trabectedin for recurrent WHO grade 2 or 3 meningiomas—Paving the road for new opportunities

PDF
Christopher A Alvarez-Breckenridge and others
Neuro-Oncology, Volume 24, Issue 5, May 2022, Pages 768–769, https://doi.org/10.1093/neuonc/noac017
Published: 31 January 2022
Journal Article

ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma

PDF
Chengchen Hu and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 888–900, https://doi.org/10.1093/neuonc/noab292
Published: 24 December 2021
Journal Article

LTBK-01. MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA

PDF
Avishay Spitzer and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi230, https://doi.org/10.1093/neuonc/noab196.924
Published: 19 November 2021
Journal Article

MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma

PDF
Julie J Miller and Daniel P Cahill
Neuro-Oncology, Volume 22, Issue 11, November 2020, Pages 1553–1554, https://doi.org/10.1093/neuonc/noaa212
Published: 14 September 2020
Journal Article

Sirtuin activation targets IDH-mutant tumors

PDF
Julie J Miller and others
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 53–62, https://doi.org/10.1093/neuonc/noaa180
Published: 26 July 2020